|
|
Impact
of brain tumour treatment on quality of life
Heimans
JJ, Taphoorn MJ
VU
Medical Centre Department of Neurology P. O. Box 7057, 1007 MB
Amsterdam, The Netherlands. jj.heimans@vumc.nl
Measurement of Health Related Quality of Life (HRQL) in brain tumour
patients is important because brain tumours and brain tumour treatment
usually affect physical, cognitive as well as emotional
functioning.
Measurement
of HRQL is important for the understanding of disease burden and for
the impact of specific tumour treatment.
Quality
of Life is a multidimensional concept consisting of physical,
psychological and social phenomena.
A
large number of Quality of Life instruments have been developed.
The
European Organization for Research and Treatment of Cancer Quality of
Life Questionnaire (EORTC QLQ-C30) and the MOS Short-Form Health
Survey are two frequently used general HRQL instruments.
A
specific brain tumour scale is the Brain Cancer Module, which is
designed to be used in combination with general questionnaires.
HRQL
measurement and neuropsychological examination were used to
investigate the impact of radiotherapy and surgery in low-grade glioma
patients and the influence of tumour volume, tumour localization,
performance status and age in both low-grade and high-grade glioma
patients.
PMID:
12195437 [PubMed - indexed for MEDLINE]
|
